Towards optimizing the sequence of bevacizumab and nitrosoureas in recurrent malignant glioma

By Wiestler Benedikt   Radbruch Alexander   Osswald Matthias   Combs Stephanie   Jungk Christine   Winkler Frank   Bendszus Martin   Unterberg Andreas   Platten Michael   Wick Wolfgang   Wick Antje  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 85-92

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma

By Tang P.   Roldan G.   Brasher P.M.A   Fulton D.   Roa W.   Murtha A.   Cairncross J.G.   Forsyth P.A.  

Journal of Neuro-Oncology, Vol. 78, Iss. 3, 2006-07 ,pp. : 311-316

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma

By  

The Oncologist, Vol. 23, Iss. 2, 2018-02 ,pp. : 157-e21

John Wiley & Sons Inc

Access to resources Recommend Favorite

Papillary endothelial hyperplasia presenting as recurrent malignant glioma

By Ong Shirley   Bruner Janet   Schellingerhout Dawid   Puduvalli Vinay  

Journal of Neuro-Oncology, Vol. 102, Iss. 3, 2011-05 ,pp. : 491-498

Springer Publishing Company

Access to resources Recommend Favorite

Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option

By Flieger Maya   Ganswindt Ute   Schwarz Silke   Kreth Friedrich-Wilhelm   Tonn Jörg-Christian   Fougère Christian   Ertl Lorenz   Linn Jennifer   Herrlinger Ulrich   Belka Claus   Niyazi Maximilian  

Journal of Neuro-Oncology, Vol. 117, Iss. 2, 2014-04 ,pp. : 337-345

Springer Publishing Company

Access to resources Recommend Favorite